arrow
返回

Recent Advances in Endomorphin Engineering

delete2010-07-23
delete45
PRE
AI
A
Attila Keresztes
A
Attila Borics
G
Géza Tóth *
DOI:10.1002/cmdc.201000077delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Recent statistics from the World Health Organization indicate that a high percentage of people worldwide suffer from a wide variety of acute or cancer-associated chronic pain. At present, with a few exceptions, the treatment of severe pain relies upon oral administration of the mu-opioid receptor-targeting opiate morphine and its surrogates under strict clinical control. In spite of the powerful in vivo efficacy of these drugs, their long-term use is limited by antinociceptive tolerance, physical dependence, and respiratory depression that evolve. As no analgesics with moderate side effect profiles are currently available for the therapy of different types of pain and stages of cancer, considerable efforts must be made in the search for opiate substitutes. Following the recognition that endogenous peptide ligands of the opioid receptors exert striking effects in various pain models, and with the recent advances in chemical synthesis methods, research interest has steadily moved toward peptide-based compounds as potential opioid analgesics. The endomorphins are an attractive set of endogenous opioid peptides that may meet the requirements of opioid-based pain management. By virtue of their excellent mu-opioid receptor labeling and favorable analgesic properties, these tetrapeptides have gained attention in recent years as potential lead compounds. The ever-increasing number of publications in this field strongly suggests that modified analogues of endomorphins could serve as potent substitutes for opiates, with a lower propensity to induce side effects. This review surveys the main results achieved over the past decade regarding the design, radiolabeling, pharmacological characterization, and structure-activity features of a large body of endomorphin derivatives.
Keyword:
endomorphins
opioids
radiolabeling
stability
structure-activity relationships
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

ChemMedChem 封面图
ChemMedChem
IF:
3.4
论文数:
5.1K
被引数:
1.0W

机构

H
Hungarian Academy of Sciences
学者数:
7.9K
论文数: 5.6K
被引数: 7.5K
引用论文

引用论文

Fixation of Radioactive Strontium in Soil
err1964-02-01
err0
PREAI
errBIRTE GREGERS-HANSEN
err分享
err收藏
Differential receptor binding characteristics of consecutive phenylalanines in μ-opioid specific peptide ligand endomorphin-2
err2007-06-01
err18
PREAI
errHonda, Takeshi; Shirasu, Naoto; Isozaki, Kaname; Kawano, Michiaki; Shigehiro, Daiki; Chuman, Yoshiro; Fujita, Tsugumi; Nose, Takeru; Shimohigashi, Yasuyuki
err分享
err收藏
Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2
err2008-06-28
err22
PREAI
errStaniszewska, Renata; Fichna, Jakub; Gach, Katarzyna; Toth, Geza; Poels, Jeroen; Broeck, Jozef Vanden; Janecka, Anna
err分享
err收藏
Conformational analysis of the endogenous μ-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling
err1998-12-03
err86
errOAAI
errPodlogar, BL; Paterlini, MG; Ferguson, DM; Leo, GC; Demeter, DA; Brown, FK; Reitz, AB
err分享
err收藏
学者 查看更多内容